Bruker EBITDA 2012-2026 | BRKR
Bruker annual and quarterly EBITDA history from 2012 to 2026. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Bruker EBITDA for the quarter ending March 31, 2026 was $4M, a 96.73% decline year-over-year.
- Bruker EBITDA for the twelve months ending March 31, 2026 was $0.279B, a 38.35% decline year-over-year.
- Bruker 2024 annual EBITDA was $0.437B, a 20.82% decline from 2023.
- Bruker 2023 annual EBITDA was $0.552B, a 5.81% increase from 2022.
- Bruker 2022 annual EBITDA was $0.522B, a 3.8% increase from 2021.
|
Bruker Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $437 |
| 2023 | $552 |
| 2022 | $522 |
| 2021 | $502 |
| 2020 | $329 |
| 2019 | $377 |
| 2018 | $327 |
| 2017 | $283 |
| 2016 | $236 |
| 2015 | $199 |
| 2014 | $165 |
| 2013 | $210 |
| 2012 | $215 |
| 2011 | $209 |
|
Bruker Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-09-30 | $4 |
| 2025-06-30 | $68 |
| 2025-03-31 | $82 |
| 2024-12-31 | $125 |
| 2024-09-30 | $119 |
| 2024-06-30 | $93 |
| 2024-03-31 | $100 |
| 2023-12-31 | $141 |
| 2023-09-30 | $151 |
| 2023-06-30 | $112 |
| 2023-03-31 | $148 |
| 2022-12-31 | $156 |
| 2022-09-30 | $152 |
| 2022-06-30 | $96 |
| 2022-03-31 | $118 |
| 2021-12-31 | $148 |
| 2021-09-30 | $135 |
| 2021-06-30 | $107 |
| 2021-03-31 | $111 |
| 2020-12-31 | $135 |
| 2020-09-30 | $102 |
| 2020-06-30 | $57 |
| 2020-03-31 | $35 |
| 2019-12-31 | $136 |
| 2019-09-30 | $107 |
| 2019-06-30 | $73 |
| 2019-03-31 | $61 |
| 2018-12-31 | $123 |
| 2018-09-30 | $85 |
| 2018-06-30 | $65 |
| 2018-03-31 | $54 |
| 2017-12-31 | $111 |
| 2017-09-30 | $68 |
| 2017-06-30 | $51 |
| 2017-03-31 | $53 |
| 2016-12-31 | $95 |
| 2016-09-30 | $60 |
| 2016-06-30 | $34 |
| 2016-03-31 | $47 |
| 2015-12-31 | $84 |
| 2015-09-30 | $42 |
| 2015-06-30 | $45 |
| 2015-03-31 | $29 |
| 2014-12-31 | $57 |
| 2014-09-30 | $23 |
| 2014-06-30 | $50 |
| 2014-03-31 | $36 |
| 2013-12-31 | $77 |
| 2013-09-30 | $47 |
| 2013-06-30 | $59 |
| 2013-03-31 | $27 |
| 2012-12-31 | $56 |
| 2012-09-30 | $74 |
| 2012-06-30 | $37 |
| 2012-03-31 | $48 |
| 2011-12-31 | $67 |
| 2011-09-30 | $51 |
| 2011-06-30 | $53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |